Vir
3 known investors
Vir Biotechnology develops treatments for infectious diseases and oncology, leveraging immunology-focused scientific capabilities. The company targets patients with unmet medical needs across these therapeutic areas.
AI & Machine LearningBiotechDigital HealthMedical Devices
Founders & leadership
MD
Marianne De BackerCEO
Investors · 3
In the news
- Hillsdale Investment Management Inc. Invests $1.44 Million in Vir Biotechnology, Inc. $VIRmarketbeat.com · 2026
- Vir Biotechnology Raises Capital Through Public Stock Offering - The Globe and Mailtheglobeandmail.com · 2026
- Vir Biotech gets U.S. funding for flu-prevention antibody | Reutersreuters.com · 2022
- SoftBank-backed Vir Biotechnology raises $143 million in U.S. IPO | Reutersreuters.com · 2019